Blood Alexander J, Fraiche Ariane M, Eapen Zubin J
Department of Medicine, Duke University Medical Center, Durham, NC, United States.
Department of Medicine, Duke University Medical Center, Durham, NC, United States.
Prog Cardiovasc Dis. 2017 Sep-Oct;60(2):171-177. doi: 10.1016/j.pcad.2017.07.003. Epub 2017 Jul 18.
Given the high prevalence of heart failure (HF) and the profound impact on morbid, mortality, and health care costs, strategies to improve outcomes and reduce cost have become progressively more attractive. Reducing HF hospitalizations as a study outcome has gained traction in recent years. The basic hypothesis of these investigations is that HF hospitalizations are preventable and harmful. This article examines advancements in pharmacotherapy, medical devices, and health care delivery techniques targeting reductions in HF hospitalizations and evaluates the role and implications of hospitalization in the natural history of HF.
鉴于心力衰竭（HF）的高患病率及其对发病率、死亡率和医疗保健成本的深远影响，改善预后和降低成本的策略变得越来越有吸引力。近年来，将减少HF住院作为一项研究成果越来越受到关注。这些研究的基本假设是HF住院是可预防的且有害的。本文探讨了旨在减少HF住院的药物治疗、医疗设备和医疗保健提供技术方面的进展，并评估了住院在HF自然病程中的作用和影响。
